Hemolytic events after the administration of lyophilized versus liquid immune globulin: an analysis of a single manufacturer's safety database

Publisher： John Wiley & Sons Inc

E-ISSN： 1537-2995|55|8|1847-1854

ISSN： 0041-1132

Source： TRANSFUSION, Vol.55, Iss.8, 2015-08, pp. : 1847-1854

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hemolytic adverse events with immune globulin products: product factors and patient risks

By  

TRANSFUSION, Vol. 55, Iss. S2, 2015-07 ,pp. : S2-S5

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hemolytic events associated with intravenous immune globulin therapy: a qualitative analysis of 263 cases reported to four manufacturers between 2003 and 2012

By  

TRANSFUSION, Vol. 55, Iss. S2, 2015-07 ,pp. : S36-S46

John Wiley & Sons Inc

Access to resources Recommend Favorite

Safety profiles of percutaneous left atrial appendage closure devices: An analysis of the Food and Drug Administration Manufacturer and User Facility Device Experience (MAUDE) database from 2009 to 2016

By  

JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, Vol. 29, Iss. 1, 2018-01 ,pp. : 5-13

John Wiley & Sons Inc

Access to resources Recommend Favorite

Do immune complexes play a role in hemolytic sequelae of intravenous immune globulin?

By  

TRANSFUSION, Vol. 55, Iss. S2, 2015-07 ,pp. : S86-S89

John Wiley & Sons Inc

Access to resources Recommend Favorite

Two Cases of Nivolumab Re-Administration after Pneumonitis as Immune-Related Adverse Events

By  

Case Reports in Oncology, Vol. 10, Iss. 1, 2017-04 ,pp. : 296-300

Karger

Access to resources Recommend Favorite